AIMS: Pleomorphic adenoma gene 1 (PLAG1) gene rearrangement is the most common genetic abnormality in pleomorphic adenoma (PA), resulting in overexpression of PLAG1 protein. PA and carcinoma ex pleomorphic adenoma (CA ex-PA) can mimic various benign and malignant salivary gland tumours. The aims of this study are to evaluate the sensitivity and specificity of PLAG1 immunohistochemistry (IHC) in the differential diagnosis of PA and CA ex-PA and to compare the PLAG1 immunohistochemical results to PLAG1 gene abnormalities as detected by fluorescence in-situ hybridisation (FISH). METHODS AND RESULTS: PLAG1 immunostaining was performed on 83 salivary gland tumours, including 23 PA, 15 CA ex-PA and 45 other salivary gland tumours. In addition, PLAG1 FISH was performed in 44 cases for the presence of gene rearrangements/amplifications. The results showed high sensitivity of PLAG1 IHC in 96% of PA; however, discordant results between PLAG1 FISH abnormalities and IHC were noted in 15 of 44 cases (34%). Seven PA, four de-novo myoepithelial carcinomas and one basal cell adenocarcinoma had negative FISH results, but were positive for IHC; while three salivary duct carcinomas (SDC) ex-PA were positive for FISH but negative for IHC. PLAG1 IHC can differentiate CA ex-PA from de-novo SDC (P = 0.02), but not from de-novo myoepithelial carcinoma. PLAG1 IHC is a sensitive marker for PA. This could be due to PLAG1 gene abnormalities beyond FISH resolution. CONCLUSIONS: A negative PLAG1 IHC might be helpful in excluding a PA diagnosis. Interestingly, in the context of CA ex-PA, FISH is more sensitive than IHC in detecting PLAG1 abnormalities.
AIMS: Pleomorphic adenoma gene 1 (PLAG1) gene rearrangement is the most common genetic abnormality in pleomorphic adenoma (PA), resulting in overexpression of PLAG1 protein. PA and carcinoma ex pleomorphic adenoma (CA ex-PA) can mimic various benign and malignant salivary gland tumours. The aims of this study are to evaluate the sensitivity and specificity of PLAG1 immunohistochemistry (IHC) in the differential diagnosis of PA and CA ex-PA and to compare the PLAG1 immunohistochemical results to PLAG1 gene abnormalities as detected by fluorescence in-situ hybridisation (FISH). METHODS AND RESULTS:PLAG1 immunostaining was performed on 83 salivary gland tumours, including 23 PA, 15 CA ex-PA and 45 other salivary gland tumours. In addition, PLAG1 FISH was performed in 44 cases for the presence of gene rearrangements/amplifications. The results showed high sensitivity of PLAG1 IHC in 96% of PA; however, discordant results between PLAG1FISH abnormalities and IHC were noted in 15 of 44 cases (34%). Seven PA, four de-novo myoepithelial carcinomas and one basal cell adenocarcinoma had negative FISH results, but were positive for IHC; while three salivary duct carcinomas (SDC) ex-PA were positive for FISH but negative for IHC. PLAG1 IHC can differentiate CA ex-PA from de-novo SDC (P = 0.02), but not from de-novo myoepithelial carcinoma. PLAG1 IHC is a sensitive marker for PA. This could be due to PLAG1 gene abnormalities beyond FISH resolution. CONCLUSIONS: A negative PLAG1 IHC might be helpful in excluding a PA diagnosis. Interestingly, in the context of CA ex-PA, FISH is more sensitive than IHC in detecting PLAG1 abnormalities.
Authors: A K Aström; M L Voz; K Kas; E Röijer; B Wedell; N Mandahl; W Van de Ven; J Mark; G Stenman Journal: Cancer Res Date: 1999-02-15 Impact factor: 12.701
Authors: Sarah L von Holstein; André Fehr; Marta Persson; Marie Nickelsen; Marianne H Therkildsen; Jan U Prause; Steffen Heegaard; Göran Stenman Journal: Ophthalmology Date: 2014-01-24 Impact factor: 12.079
Authors: Almas R Juma; Pauliina E Damdimopoulou; Sylvia V H Grommen; Wim J M Van de Ven; Bert De Groef Journal: J Endocrinol Date: 2015-11-17 Impact factor: 4.286
Authors: Ben Davidson; Vera Maria Abeler; Ellen Hellesylt; Arild Holth; Ie-Ming Shih; Tone Skeie-Jensen; Li Chen; Yanqin Yang; Tian-Li Wang Journal: Gynecol Oncol Date: 2012-11-21 Impact factor: 5.482
Authors: Andrea Zatkova; Jean-Marie Rouillard; Wolfgang Hartmann; Barbara J Lamb; Rork Kuick; Markus Eckart; Dietrich von Schweinitz; Arend Koch; Christa Fonatsch; Torsten Pietsch; Sam M Hanash; Katharina Wimmer Journal: Genes Chromosomes Cancer Date: 2004-02 Impact factor: 5.006
Authors: Beatriz Samara de Brito; Natália Giovanelli Gaspar; Erika Said Abu Egal; Celeste Sanchez-Romero; Antonio Santos Martins; Álfio José Tincani; Rogério de Oliveira Gondak; Oslei Paes de Almeida; Luiz Paulo Kowalski; Albina Altemani; Fernanda Viviane Mariano Journal: Virchows Arch Date: 2016-07-06 Impact factor: 4.064
Authors: Adepitan A Owosho; Olufunlola M Adesina; Oluwole Odujoko; Hezekiah Akinyemi; Akinwumi Komolafe; Simon Tadros; Robert Bauer; Kurt F Summersgill Journal: Int J Clin Exp Pathol Date: 2022-02-15
Authors: Catherine T Chung; Cristina R Antonescu; Brendan C Dickson; Rose Chami; Paula Marrano; Rong Fan; Mary Shago; Meera Hameed; Paul S Thorner Journal: Genes Chromosomes Cancer Date: 2020-12-30 Impact factor: 5.006
Authors: Yajuan J Liu; Wenjing Wang; Jeffrey Yeh; Yu Wu; Jose G Mantilla; Christopher D M Fletcher; Robert W Ricciotti; Eleanor Y Chen Journal: Mod Pathol Date: 2021-03-16 Impact factor: 7.842